NCT04009044 2025-10-09
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Northwestern University
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT02993159 2024-12-18
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Northwestern University
Phase 2 Completed
NCT03063619 2024-02-22
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02067741 2023-06-27
CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer
Swiss Cancer Institute
Phase 2 Terminated